D-0889-2018 Class II Terminated
FDA drug recall D-0889-2018 was initiated by Advanced Pharma Inc. on Jun 20, 2018 and is designated Class II. Reason for recall: Subpotent Drug: final drug concentration is subpotent as compared to the concentration indicated on the label. The recall status is terminated (terminated Apr 3, 2019). Affected quantity: 100 syringes.
Recall Details
- Product Type
- Drugs
- Report Date
- Jul 4, 2018
- Initiation Date
- Jun 20, 2018
- Termination Date
- Apr 3, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 100 syringes
Product Description
fentanyl Citrate USP 5 mcg in 0.9% Sodium Chloride USP 0.5 mL, 10 mcg per mL prefilled syringe, Rx only, Advanced Pharma an FDA Regulated 503B Outsourcing Facility 9265 Kirby Dr., Houston, TX 77054, NDC 15082-210-72.
Reason for Recall
Subpotent Drug: final drug concentration is subpotent as compared to the concentration indicated on the label.
Distribution Pattern
Distributed to one medical center in Fort Worth, TX.
Code Information
Lot #: 6/12/18 0432 149-21072S, BUD 9/10/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0889-2018
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 26, 2026